Synthesis and receptor binding of Cys-endomorphin

Biomedical Research

Volumn 20, Issue 5, 1999, Pages 253-258

  Szücs, Mária ^a   Baláspiri, Lajos ^b   Tóth, Géza ^a   Yanaihara, Noboru ^c  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b CHEMICAL RESEARCH CENTER   (Hungary)

^c Yanaihara Institute Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DELTORPHIN; ENDORPHIN DERIVATIVE; MU OPIATE RECEPTOR; NALOXONE; SIGMA OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; RAT;

ANIMALIA;

EID: 0343851749     PISSN: 03886107     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.20.253     Document Type: Article

References (29)

1. Baláspiri L, Ötvös L. Sr., Krajcsovits F. (1996) Application of Advanced ChemTech peptide synthetizer for synthesis of oligonucleotids, too. News Letter Adv. ChemTech 6, 4-5.
2. Bradford M M. (1986) A rapid and sensitive method for the quatitation of microgram quantities of protein utilizing the principle of dye-binding. Anal. Biochem. 72, 248-254.
3. 1.butyl side chain protection. Int. J. Peptide Protein Res. 15, 59-66.
4. Chang J K, Fong B T W, Pert A, Pert C B. (1976) Opiate receptor affinities and behavioral effects of enkephalin: Structure-activity relationship of ten synthetic peptide analogues. Life Sci. 18, 1473-1482.
5. Charpentier S, Sagan S, Delfour A, Nicolas P. (1991) Dermenkephalin and deltorphin I reveal similarities within the ligand-binding domains of μ-and δ-opioid receptors and an additional address subsite on the δ-receptor. Biochem. Biphys. Res. Commun. 179, 1161-1168.
6. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
7. Fukuda K, Terasako K, Kato S, Mori K. (1995) Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ-and μ-opioid receptors. FEBS Letters 373, 177-181.
8. Hughes J, Smith T W, Kosterlitz H W, Fothergill L A, Morgan B A, Morris H R. (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258, 577-579.
9. Fornié-Zaluski M C, Gacel G, Maigret B, Premilat S, Roques B P. (1981) Structural requirements for specific recognition of μ or δ opiate receptors. Mol. Pharmacol. 20, 484-491.
10. Goldstein A, Fischli W, Loewney L I, Hunkapiller M, Hood L. (1981) Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc. Natl. Acad. Sci. USA 78, 7219-7223.
11. Kaiser E, Choleschott R L, Bosshinger C D, Cook P J. (1970) Colour test for the detection of free amino groups in solid phase synthesis of peptides. Anal Chem 34, 595-598.
12. Li C H, Chung, D. (1976) Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc. Natl. Acad. Sci. USA 73, 1145-1148.
13. Liebmann C, Szücs M, Neubert K, Hartrodt B, Arold H, Brath A. (1985) Opiate receptor binding affinities of some D-amino acid substituted β-casomorphin analogs. Peptides. 7, 195-199.
14. Lord J A H, Waterfield A A, Hughes J, Kosterlitz H W. (1977) Endogenous opioid peptides: Multiple agonists and receptors. Nature 267, 495-499.
15. Mansour A, Hoversten M T, Taylor L P, Watson S J, Akil H. (1995) The cloned μ, δ and N receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res. 700, 89-98.
16. Martin-Schild S, Zadina J E, Gerai A A, Vígh S, Kastin A J. (1997) Localization of endomorphin-2 like immunoreactivity in the rat medulla and spinal cord. Peptides 18, 1641-1649.
17. Matthes H W, Maldonado, R, Simonin F, Valverde O, Slowe S. Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques B P, Kieffer B L. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819-823.
18. Morley J S. (1980) Structure-activity relationship of enkephalin-like peptides. Ann. Rev. Pharmacol. Toxicol. 20, 81-110.
19. Munson P J, Rodbard D. LIGAND: (1980) a versatile computeried approach for the characterization of ligand binding studies. Anal. Biochem. 107, 220-227.
20. 5,6-Deltorphin II. Neuropeptides 26, 261-265.
21. Reisine, T. and Bell, G. (1993) Molecular biology of opioid receptors. Trends in Neurosci. 16, 506-510.
22. Spetea M, Monory K, Tömböly C, Tóth G, Tzavari E, Benyhe S, Hanoune J, Borsodi A. (1998) In vitro binding and signaling profile of the novel μ opioid receptor agonist for endomorphin 2 in rat brain membranes. Biochem. Biophys. Res. Commun. 250, 720-725.
23. Surratt C K, Johnson P S, Moriwaki A, Seidleck B K, Blaschak C J, Wang J B, Uhl G R. (1994) -μ Opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269, 20548-20553.
24. Szücs M, Coscia C J. (1990) Evidence for δ-opioid binding and GTP-regulatory proteins in 5-day-old rat brain membranes. J. Neurochem. 54, 1419-1425.
25. 5-enkephalin methyl ester. FEBS Letters 179, 87-90.
26. 3H)-Naloxone of high specific activity. J. Label. Comp. Radiopharm. 19, 1021-1029.
27. Watson S, Arkinstall S. In: "The G-Protein Linked Receptor FactsBook' (ed. Watson S, Arkinstall S.) Academic Press, London, 1994, pp. 1-291.
28. Watson B, Meng F, Thompson R C, Akil H. (1995) Structural studies of the mu opioid receptor using chimeric constructs. Analgesia 1: 4-6, 825-828.
29. Zadina J E, Hackler L, Ge L Y, Kastin A J. (1997) A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386, 499-502.